BRIAN MASTERSON: Open Payments
NPI 1053522359 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$128 in 6 payments from 6 companies in 2025. Trend: 2023 $725 · 2024 $55 · 2025 $128
Food & beverage: $128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, FANAPT, TRINTELLIX, Qelbree, REXULTI.
Industry payments across OH — which companies pay providers there.
